Risk of market volatility caused by COVID-19 and other factors
First written in FY2022-Q1. 2 of 3 entries say "Restated". Latest entry: FY2024-Q1.
1 other company's latest entry also says "Restated".
- FY2024-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, there were no new occurrences of the major risks that management recognises could materially affect the financial position, operating results or cash flows of the Group among the matters relating to business conditions, financial conditions and other matters described in the quarterly report, and no material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
The company explained that there have been no significant changes regarding the risk of market fluctuations caused by COVID-19 and other factors. - FY2022-Q2RestatedAnnual report
「Deliveries and sales activities are progressing generally as planned against the annual business plan, and there is currently no change to the full-year earnings forecast. However, if fluctuations arise in transaction markets or other markets due to the impact of COVID-19 or other circumstances, the company's performance may also be affected.」
Although the delivery of electronic medical records and the sale of solar power generation projects are generally progressing in line with the annual plan, the risk that market fluctuations caused by COVID-19 and other factors could affect business performance remains. - FY2022-Q1First statedAnnual report
「Deliveries and sales activities are progressing generally as planned against the annual business plan, and there is currently no change to the full-year earnings forecast. However, if fluctuations arise in transaction markets or other markets due to the impact of COVID-19 or other circumstances, the company's performance may also be affected.」
The buying and selling markets related to the delivery of electronic medical records and the sale of solar power generation projects have been identified as a new risk, as market fluctuations caused by COVID-19 and other factors could affect business performance.